Skip to content

Ketamine: all studies

Page 427 of 449: studies 4,261 to 4,270 of 4,490, newest first. Back to the ketamine overview

Research

Investigational drugs in recent clinical trials for treatment-resistant depression

Expert Review of Neurotherapeutics January 16, 2017 Ricardo Pablo Garay, Carlos A. Zarate, Thomas Charpeaud et al. 79 citations

INTRODUCTION: The authors describe the medications for treatment-resistant depression (TRD) in phase II/III of clinical development in the EU and USA and provide an opinion on how current treatment can be improved in the near future. Areas covered: Sixty-two trials were identified in US and EU clinical trial registries that included six investigational compounds in recent phase III development...

[Elucidation of the Role of Dorsal Raphe Serotonergic Neurons in Mood Regulation Using Pharmacological and Viral Vector-based Approaches].

Yakugaku Zasshi 2017 Kazuki Nagayasu

Growing evidence indicates that serotonergic neurons play a crucial role in brain function and dysfunction, such as in major depressive disorder. However, the complexity of serotonergic projections severely hampers the elucidation of their precise mechanisms. Here we summarize our recent studies on the effects of ketamine and olanzapine, which have been reported to be effective in...

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity

Neural Plasticity 2017 Yu-Jhen Huang, Hsien-Yuan Lane, Chieh-Hsin Lin 77 citations

Major depressive disorder is a severe and complex mental disorder. Impaired neurotransmission and disrupted signalling pathways may influence neuroplasticity, which is involved in the brain dysfunction in depression. Traditional neurobiological theories of depression, such as monoamine hypothesis, cannot fully explain the whole picture of depressive disorders. In this review, we discussed new...

Structure and Dynamics of Brain Lobe's Functional Networks at the Onset of Anesthesia-Induced Loss of Consciousness

arXiv Preprint Archive November 15, 2016 Eduardo C. Padovani preprint

Anesthetic agents are neurotropic drugs capable of inducing significant alterations in the thalamocortical system, promoting a profound decrease in awareness and level of consciousness. There is experimental evidence that general anesthesia affects large-scale functional networks, leading to alterations in the brain's state. However, the specific impact on the network structure assumed by...

Full text (opens in new tab) Consciousness studies Q-bio.nc Anesthesiology Brain networks

Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathology.

Schizophrenia Research November 1, 2016 David A Cox, Michael G Gottschalk, Hendrik Wesseling et al.

Pharmacological and genetic rodent models of schizophrenia play an important role in the drug discovery pipeline, but quantifying the molecular similarity of such models with the underlying human pathophysiology has proved difficult. We developed a novel systems biology methodology for the direct comparison of anterior prefrontal cortex tissue from four established glutamatergic rodent models...

DOI: 10.1016/j.schres.2016.06.012 (opens in new tab) Full text (opens in new tab) Molecular validity Proteomics Psychosis models Schizophrenia +1

Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.

The American Journal of Drug and Alcohol Abuse November 1, 2016 Joseph J Palamar, Patricia Acosta, Scott J Sherman et al. 73 citations

Novel psychoactive substances (NPSs) continue to emerge in the United States and worldwide. Few epidemiological studies have examined the prevalence and correlates of use. We examined the extent of NPS use in a high-risk population-attendees of electronic dance music (EDM) parties at nightclubs and festivals. We surveyed 682 adults (age 18-25) entering EDM events at nightclubs and festivals in...

DOI: 10.1080/00952990.2016.1181179 (opens in new tab) Full text (opens in new tab) Novel psychoactive substances Synthetic cannabinoids Synthetic cathinones Young adults +13

CRITICAL REVIEW OF AVAILABLE TREATMENT OPTIONS FOR TREATMENT REFRACTORY DEPRESSION AND ANXIETY - CLINICAL AND ETHICAL DILEMMAS.

Medicinski pregled October 2016 Dušan Kolar, Michael V Kolar

Treatment-resistant mood and anxiety disorders require an intensive therapeutic approach, and it should balance benefits and adverse effects or other potential detrimental effects of medications. The goal of treatment is to provide consistent and lasting improvement in symptoms of depression and anxiety. Beozodiazepines are effective for anxiety symptoms, but with no sustained treatment...

An Impaired Driver Found to be Under the Influence of Methoxetamine.

Journal of Analytical Toxicology October 1, 2016 Timothy C Fassette, Afton Martinez

The popularity of designer drugs has increased over the past few years as users seek new, cheap and sometimes "legal" ways to get high. This case report focuses on a case that happened in the City of Henderson, Nevada, which involved the designer drug methoxetamine. Methoxetamine is a psychoactive compound that is structurally related to ketamine and reported to have similar effects. These...

Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014

Substance Abuse Treatment, Prevention, and Policy September 23, 2016 Ling‐yi Feng, Wenjing Yu, Wei-Ting Chang et al. 49 citations

While the problem of methamphetamine still lingers, NPS have emerged as a new issue in both countries. However, the NPS pattern was different between Taiwan and Korea. Although the controlled NPS items in Taiwan were far less than those in Korea, the quantity of total NPS seizures, especially with ketamine, was much larger in Taiwan than in Korea. Different NPS pattern may also imply they were...

DOI: 10.1186/s13011-016-0078-x (opens in new tab) Cannabis Heroin Environmental health Methamphetamine +1

Self Medication with Methoxetamine as an Analgesic Resulting in Significant Toxicity.

Pain Medicine September 1, 2016 K. Maskell, Michael D. Bailey, S. R. Rose

Dear Editor, Methoxetamine (MXE) is a non-scheduled arylcyclohexylamine drug of abuse with clinical effects similar to ketamine or phencyclidine [1]. We report a case of MXE toxicity after self-medicating for treatment of chronic foot pain. A 29-year-old man was brought to the emergency department (ED) for altered mental status. He was apprehended by police after running into the street and...